lymphocyt
import
innat
adapt
immun
respons
innat
lymphocyt
repres
heterogen
group
cell
includ
cell
lack
receptor
antigen
group
innat
lymphoid
cell
natur
killer
nk
cell
prototyp
exampl
innat
lymphocyt
express
antigen
receptor
includ
b
cell
natur
killer
nkt
cell
cell
innat
lymphocyt
rel
rare
circul
lymphoid
tissu
found
mucos
surfac
repres
portal
entri
bodi
chapter
focu
laboratori
work
one
major
antigenspecif
subset
innat
lymphocyt
cell
cell
import
role
innat
adapt
immun
respons
wound
heal
tissu
homeostasi
mani
outstand
review
biolog
function
cell
select
relev
topic
chapter
list
tabl
briefli
cell
express
uniqu
cell
receptor
tcr
recogn
self
foreign
antigen
absenc
requir
present
major
histocompat
complex
mhc
class
class
ii
molecul
featur
lead
broad
rang
innat
respons
pathogen
well
recognit
stress
tumor
cell
subset
cell
defin
restrict
tcr
gene
usag
addit
express
variou
surfac
molecul
preprogram
function
respons
imprint
prior
egress
thymu
cell
also
express
myriad
innat
receptor
tolllik
receptor
tlr
scaveng
receptor
lectin
receptor
directli
sens
infecti
agent
receptor
along
cytokin
receptor
finetun
sens
respons
cell
adapt
tissu
microenviron
tcr
stimul
lead
varieti
function
respons
cytolysi
cytokin
product
regulatori
effect
even
phagocytosi
antigen
present
depend
activ
receptor
coreceptor
cell
respond
rapidli
extern
signal
lead
earli
cytokin
respons
varieti
diseas
set
furthermor
uniqu
posit
virtual
portal
entri
bodi
type
innat
immun
respons
critic
inde
cell
like
innat
lymphocyt
found
mucos
surfac
make
larg
fraction
intraepitheli
lymphocyt
popul
also
recruit
site
inflamm
tumor
growth
tissu
insult
addit
tcr
cell
express
varieti
nontcr
receptor
affect
function
cell
express
nk
ctype
lectinlik
receptor
recogn
cellular
stress
protein
result
cellular
activ
also
express
tumor
necrosi
factor
tnf
receptor
famili
molecul
costimulatori
receptor
tcr
also
express
tcrstimul
tumorreact
cell
ig
superfamili
also
tcr
coreceptor
aryl
hydrocarbon
receptor
ahr
gener
known
role
homeostasi
mucos
cell
also
express
mous
cell
produc
innat
interleukin
well
mous
skin
cell
subset
cell
also
express
variou
cytokin
receptor
contribut
activ
etc
andfin
tune
function
respons
express
pathogenassoci
molecular
pattern
receptor
detect
cell
includ
anoth
lectin
receptor
receptor
fungal
plant
bacterialderiv
polysaccharid
tlr
scaveng
receptor
nodlik
receptor
though
focu
chapter
cell
also
express
varieti
receptor
downregul
function
exampl
includ
killer
cell
immunoglobulinlik
receptor
leukocyt
immunoglobulinlik
receptor
b
lymphocyt
attenu
program
cell
death
receptor
regulatori
receptor
suppress
function
andor
prolifer
cell
cell
ancient
immun
cell
lineag
found
jaw
vertebr
phylogenet
evid
suggest
progenitor
cell
b
cell
predat
adapt
immun
surpris
retain
mani
innat
function
similar
monocyt
macrophag
zebrafish
cell
phagocyt
present
antigen
addit
express
character
transcript
express
subset
bovin
cell
primari
outcom
studi
recognit
multipl
transcript
similar
found
monocyt
macrophag
cell
indic
innat
function
part
studi
detect
blymphocyteinduc
matur
protein
transcript
bovin
cell
also
known
key
regul
differenti
hematopoiet
cell
myeloid
b
cell
therefor
detect
cell
subset
notabl
time
recogn
signific
confirm
express
transcript
rest
bovin
cell
cell
recent
find
confirm
innat
function
cell
appropri
context
transcript
analys
bovin
cell
also
suggest
express
transcript
encod
solut
carrier
also
denot
natur
resistanceassoci
macrophag
protein
cell
dival
metal
transport
thought
express
myeloid
macrophag
cell
import
effect
respons
intracellular
bacteri
infect
enhanc
signal
activ
macrophag
defin
protein
express
similar
function
activ
bovin
human
cell
nk
cell
express
strongli
correl
activ
particular
express
interferon
gamma
cell
thu
addit
monocyt
macrophag
protein
also
express
cell
function
relev
anoth
similar
myeloid
cell
abil
cell
number
speci
process
present
antigen
effect
antigen
present
requir
initi
adapt
immun
studi
primarili
convent
antigenpres
cell
apc
dendrit
cell
dc
activ
macrophag
b
cell
cell
express
array
surfac
receptor
scaveng
receptor
facilit
uptak
particul
antigen
subset
also
express
mhc
class
ii
necessari
coreceptor
effect
antigen
present
cell
antigen
uptak
present
cell
first
shown
bovin
cell
also
shown
mhc
class
ii
express
antigen
present
enhanc
bovin
cell
viral
infect
similar
function
describ
porcin
human
mous
cell
cell
contact
bacteria
transit
cytokineproduc
cell
phagocyt
apc
demonstr
function
plastic
phagocyt
capac
cell
augment
opson
combin
studi
show
subset
cell
variou
speci
induc
present
antigen
via
mhc
class
ii
clearli
cell
uniqu
role
innat
immun
similar
respect
monocyt
macrophag
involv
subsequ
initi
antigendepend
acquir
immun
ligat
receptor
express
cell
lead
potent
cytolyt
respons
vii
new
novel
approach
mucos
vaccin
develop
stress
infect
malign
cell
though
cell
permiss
growth
tumor
ligat
tcr
combin
receptor
cytokin
receptor
receptor
enhanc
direct
cytotox
respons
along
cytokin
product
cytotox
function
cell
conserv
across
speci
exampl
granzym
b
perforin
fasl
express
cell
bovin
peripher
blood
mononuclear
cell
pbmc
fasl
express
increas
upon
activ
cell
perforin
express
also
found
bison
cell
perforin
granzym
faslfa
tnfrelat
apoptosisinduc
ligand
pathway
also
featur
human
cell
cytotox
activ
cell
like
play
import
role
multipl
speci
optim
immun
respons
cell
subset
malign
infect
cell
anoth
import
function
respons
cell
regul
tissu
environ
cytokin
gener
cytokin
includ
drive
inflammatori
respons
contribut
downstream
adapt
immun
respons
well
cytokin
affect
epitheli
cell
health
tissu
homeostasi
although
number
cytokin
produc
cell
larg
tissu
cytokin
keratinocyt
growth
factor
kgf
insulinlik
growth
factor
igf
particular
import
function
subset
cell
potent
activ
cell
myeloid
lineag
contribut
downstream
inflammatori
respons
mice
cell
major
sourc
innat
earli
respons
infect
two
popul
cell
contribut
respons
one
refer
natur
cell
acquir
effector
function
prior
egress
thymu
cell
found
mucos
tissu
thought
earli
respond
infecti
insult
anoth
popul
refer
induc
cell
rapidli
acquir
effector
function
egress
thymu
respons
antigen
cytokin
peripheri
report
suggest
although
human
larg
anim
cell
produc
induc
phenotyp
may
major
earli
sourc
cytokin
speci
although
clearli
protect
instanc
thought
import
earli
innat
immun
respons
dysregul
product
lead
excess
also
pathogen
kgf
igf
also
produc
tissu
cell
import
maintain
epitheli
cell
health
effect
wound
repair
respons
though
defin
import
tissu
homeostasi
respons
also
import
host
defens
sinc
health
epitheli
cell
barrier
contribut
protect
variou
pathogen
creation
homeostat
environ
commens
microbiota
cell
shown
respond
particip
host
defens
respons
varieti
infecti
diseas
includ
viral
bacteri
parasiteinduc
diseas
mani
mucos
surfac
recent
cell
found
import
protect
emerg
virus
chikungunya
west
nile
viru
hiv
infect
peripher
subset
human
cell
sever
deplet
complet
recov
even
patient
success
antiretrovir
treatment
deficit
may
increas
likelihood
secondari
infect
could
critic
target
new
immunotherapi
hiv
patient
cell
clearli
import
antibacteri
immun
sourc
earli
human
cell
preprogram
recognit
bacteri
phosphoantigen
particularli
import
protect
mycobacterium
legionella
infect
human
cell
expand
salmonella
enterica
serovar
typhimurium
st
infect
intestin
mucosa
sourc
earli
bovin
cell
also
respond
oral
st
infect
cell
also
play
critic
role
protect
infect
brucella
sp
facult
intracellular
bacteria
appear
primarili
product
found
mice
cattl
sheep
howev
result
show
contribut
mous
cell
infect
anoth
emerg
intracellular
pathogen
coxiella
burnetii
unpublish
result
follow
mucos
infect
peripher
infect
mous
cell
also
found
role
downstream
memori
immun
respons
listeria
infect
thu
cell
play
import
role
respons
mani
differ
bacteri
infect
suggest
specif
stimul
may
contribut
protect
may
potenti
replac
least
reduc
need
antibiot
could
consid
new
target
futur
vaccin
develop
cell
also
play
protect
role
parasit
infect
respond
protect
follow
initi
infect
malaria
plasmodium
falciparum
owe
recognit
phosphoantigen
produc
parasit
howev
upon
subsequ
infect
number
cell
drop
similar
situat
longterm
hiv
infect
nonetheless
higher
number
function
cell
correl
greater
protect
reinfect
plasmodium
also
increas
symptom
upon
infect
sourc
similarli
first
instanc
bovin
cell
demonstr
protect
relat
parasit
inde
instanc
protect
pathogen
cell
similarli
protect
human
anim
common
featur
across
speci
provid
rational
use
variou
anim
model
test
role
import
cell
diseas
set
relev
human
lead
creation
strateg
platform
tcelltarget
vaccin
develop
cell
character
uniqu
specif
tissu
locat
rapid
respons
extern
signal
insult
exist
preprogram
induc
effector
subset
combin
abil
expand
cell
vitro
critic
role
varieti
infecti
cancer
diseas
set
cell
target
new
immunotherapeut
human
tcr
tlr
agonist
studi
effect
enhanc
cell
function
prenyl
phosphat
bisphosphon
directli
indirectli
drive
expans
cytokin
product
major
subset
circul
cell
pursu
treatment
certain
tumor
infect
two
approach
use
first
approach
cell
expand
larg
number
vitro
adopt
transfer
patient
second
approach
agonist
given
directli
patient
induc
respons
vivo
vivo
respons
cell
agonist
impress
lead
signific
expans
tissu
lung
product
immun
cytokin
note
though
origin
pursu
cancer
treatment
potenti
applic
phosphoantigen
stimul
cell
infecti
diseas
recent
demonstr
mycobacterium
tuberculosi
infect
primat
applic
therapeut
approach
stimul
cell
limit
human
nonhuman
primat
sinc
cell
respons
prenyl
phosphat
restrict
primat
cell
therapeut
approach
increas
cell
activ
focus
receptor
tlr
scaveng
receptor
recent
endeavor
expand
number
materi
enhanc
activ
cell
multipl
speci
achiev
screen
variou
natur
product
librari
sourc
natur
product
includ
nutrit
supplement
assess
capac
upregul
receptor
express
primari
cell
therebi
enhanc
respons
absenc
antigen
followup
function
assay
examin
cell
type
specif
induc
cytokin
respons
benefit
variou
infecti
diseas
model
two
class
plant
productspolyphenol
polysaccharidesand
one
exampl
microbi
product
stimul
cell
came
studi
summar
class
plant
polyphenol
call
oligomer
procyanidin
opc
produc
appl
grape
plant
determin
potent
prime
agent
cell
sever
studi
suggest
ingest
plant
berri
compound
contain
polyphenol
expand
human
cell
vivo
studi
show
opc
appl
peel
prime
human
mous
bovin
cell
nk
cell
instanc
enhanc
respons
secondari
signal
provid
cytokin
antigen
group
also
found
opc
expand
mous
cell
vivo
stimul
goat
cell
opcmedi
cell
respons
increas
express
activ
marker
cell
activ
prolifer
absenc
secondari
signal
cytokin
tcr
engag
opc
treatment
also
induc
product
restrict
number
cytokin
mani
act
myeloid
cell
colonystimul
factor
csf
chemokin
variou
tissu
growth
factor
one
consequ
opc
treatment
bovin
human
cell
signific
extens
stabil
csf
chemokin
transcript
abil
extend
function
lifetim
transcript
enabl
cell
rapidli
robustli
produc
certain
cytokin
respons
secondari
signal
importantli
opc
show
bioactiv
ingest
safe
rang
dose
speci
test
supplement
increas
cell
peripheri
tissu
follow
oral
deliveri
larg
dose
opc
mice
signific
reduct
inflamm
seen
dextran
sulfat
sodium
dss
induc
coliti
antiinflammatori
effect
independ
cell
requir
cell
interestingli
absenc
cell
ragproteindepend
popul
cell
like
cell
respons
robust
noninflammatori
cytokin
respons
opc
treat
mice
dss
model
consist
observ
opc
ingest
mice
shown
induc
increas
level
gcsf
circul
without
obviou
deleteri
inflamm
unpublish
result
induc
gcsf
normal
consid
proinflammatori
respons
also
contribut
protect
immun
support
certain
instanc
clearli
much
learn
myriad
effect
ingest
opc
cell
immun
cell
eg
cell
vivo
expect
potent
plant
chemic
eg
opc
deriv
product
may
safe
novel
immunotherapeut
immunomodul
set
studi
also
identifi
uniqu
polysaccharid
variou
plant
potent
agonist
cell
cell
immun
system
first
sourc
polysaccharid
agonist
funtumia
elastica
bark
yamoa
yamoa
polysaccharid
activ
well
immun
cell
monocyt
given
vivo
enhanc
protect
infect
optim
activ
prime
cell
polysaccharid
requir
monocyt
macrophag
mix
vitro
cultur
follow
initi
character
yamoa
polysaccharid
similar
activ
defin
extract
plant
includ
tansi
unpublish
junip
unpublish
recent
mani
polysaccharid
prepar
test
except
gener
posit
limulu
amebocyt
lysat
assay
lipopolysaccharid
polysaccharid
respons
conserv
cell
across
speci
includ
human
cattl
mice
monocyt
macrophag
also
activ
polysaccharid
requir
optim
respons
cell
instil
polysaccharid
lung
mice
induc
dosedepend
product
accumul
myeloid
cell
activ
local
dc
macrophag
subsequ
shown
prophylact
therapeut
nasal
administr
polysaccharid
significantli
enhanc
host
innat
defens
respons
intracellular
bacteri
pathogen
francisella
tularensi
burkholderia
pseudomallei
protect
could
also
achiev
follow
oral
deliveri
although
respons
variabl
mechan
action
studi
show
polysaccharid
enhanc
express
cell
nk
cell
follow
f
tularensi
b
pseudomallei
infect
inhibit
block
protect
effect
polysaccharid
thu
stimul
cell
well
innat
immun
cell
similar
plant
agonist
subsequ
type
helper
cellassoci
respons
could
therapeut
applic
bacteri
infect
sinc
commonli
ingest
dietari
supplement
shown
therapeut
benefit
follow
oral
deliveri
examin
effect
agonist
two
addit
intestin
model
dysbiosi
condit
usual
induc
antibiot
use
normal
flora
disrupt
state
lead
increas
suscept
infect
coliti
mice
dysbiosi
treat
polysaccharid
assess
whether
polysaccharid
could
aid
recoveri
suscept
state
cytokin
express
mesenter
lymph
node
mln
spleen
cell
measur
feed
polysaccharid
induc
express
supernat
fluid
cultur
mln
spleen
cell
treat
mice
also
detect
serum
mice
express
also
increas
spleen
cell
polysaccharidef
mice
similar
previou
find
use
nasal
administr
advers
effect
note
mice
model
chemic
induc
coliti
mice
fed
reduc
deleteri
inflammatori
respons
gut
consid
advers
effect
follow
ingest
polysaccharid
could
repres
safe
novel
approach
stimul
cell
innat
cell
potenti
promot
innat
protect
homeostat
function
mucos
surfac
next
studi
aim
examin
potenti
receptor
involv
sens
respons
polysaccharid
immun
cell
respons
lost
mice
lack
function
innat
adaptor
protein
howev
neutrophil
still
recruit
peritoneum
mice
follow
intraperiton
inject
role
receptor
particularli
investig
sinc
produc
immun
cell
follow
ingest
result
demonstr
polysaccharid
contain
appropri
linkag
recognit
use
inhibit
elisa
furthermor
polysaccharid
specif
block
bind
antibodi
immun
cell
flow
cytometri
base
assay
thu
polysaccharid
bind
multipl
innat
immun
cell
receptor
contribut
uniqu
effect
innat
like
downstream
adapt
immun
respons
polysaccharid
consid
new
mucos
immunomodul
molecul
regul
antigenspecif
immun
respons
inflamm
activationbas
screen
assay
result
detect
robust
agonist
activ
cell
multipl
microbi
extract
unpublish
result
one
agonist
determin
amphotericin
b
amb
produc
streptomyc
nodosu
amb
commonli
use
antifung
drug
previous
shown
stimul
innat
immun
cell
amb
induc
express
cytokin
macrophag
mediat
tlr
recognit
amb
treatment
bovin
pbmc
lead
increas
express
select
cell
activ
bovin
monocyt
nk
cell
enhanc
nk
cell
addit
cultur
induc
robust
antigenindepend
prolifer
treat
cell
agonist
activ
amb
restrict
cattl
similar
effect
seen
express
activ
marker
prolifer
cell
human
mice
well
thu
respons
highli
conserv
separ
studi
amb
shown
increas
product
mous
lung
cell
follow
vitro
infect
costimul
avirul
c
burnetii
bacteria
amb
also
enhanc
antibodi
respons
ovalbumin
use
immun
adjuv
thu
amb
potenti
enhanc
innat
acquir
respons
infect
function
vaccin
adjuv
sinc
bovin
cell
nk
cell
respond
amb
low
nontox
dose
next
experi
aim
test
vivo
model
infecti
enterocol
calv
given
one
intraven
inject
approxim
mgkg
amb
salin
hour
prior
st
infect
oral
rout
ambtreat
calv
lower
fever
overal
reduc
morbid
shed
less
bacteria
environ
comparison
control
calv
thu
amb
protect
diseas
sever
reduc
level
shed
bacteria
result
suggest
amb
could
use
potent
immunomodulatori
molecul
enhanc
diseas
resist
st
calv
effort
continu
assess
immun
protect
effect
amb
young
calv
highli
prone
infect
bovin
calv
less
weekold
variabl
colostrum
statu
experi
broad
spectrum
natur
scour
respiratori
maladi
first
week
month
life
symptom
typic
caus
rotaviru
coronaviru
cryptosporidium
combin
viru
parasit
infect
regardless
caus
calv
treat
hydrat
therapi
sign
secondari
bacteri
infect
becom
appar
antibiot
administ
calv
like
preexpos
varieti
pathogen
would
explain
earli
diseas
occur
hous
indoor
clean
facil
year
data
occurr
natur
ill
facil
studi
direct
test
whether
earli
minim
treatment
amb
could
potenti
use
broadspectrum
prophylact
immunomodul
dose
mgkg
inject
intraven
previous
describ
use
studi
approxim
less
dose
given
patient
antifung
treatment
determin
nontox
calv
two
treat
group
n
per
group
one
group
receiv
singl
inject
amb
day
arriv
facil
amb
second
group
receiv
initi
dose
day
arriv
second
dose
day
amb
thu
first
day
calv
treat
one
dose
amb
health
condit
assess
evalu
anim
subject
appear
attitud
appetit
temperatur
puls
respir
fecal
consist
treatment
scale
health
condit
assess
calv
twice
daili
compar
calv
acquir
month
span
experi
receiv
treatment
given
period
studi
talli
number
day
calv
perfect
health
score
score
calv
receiv
one
inject
amb
improv
health
assess
first
day
comparison
calv
receiv
treatment
fig
period
extend
first
day
case
untreat
calv
compar
amb
amb
group
wherea
one
dose
amb
appear
benefit
short
term
first
day
amb
treatment
last
effect
contrast
calv
treat
amb
longerlast
posit
benefit
fig
data
suggest
minim
earli
dose
innat
immun
stimul
could
benefit
health
livestock
extend
period
especi
import
cattl
subject
repeat
infect
earli
life
also
provid
proof
principl
broadspectrum
posit
bodi
capac
vari
appropri
respons
depend
environment
signal
cell
optim
target
novel
immunotherapeut
vaccin
develop
tcr
tlr
agonist
stimul
cell
alreadi
use
extens
new
cancer
treatment
ampl
data
suggest
cell
might
also
specif
stimul
protect
infecti
inflammatori
diseas
consid
grow
concern
use
overus
antibiot
critic
novel
approach
counter
infecti
agent
pursu
